Crystal meth: a particular form of methamphetamine;Crystal meth : une forme de méthamphétamine

Presse Medicale

Volumn 38, Issue 1, 2009, Pages 63-67

  Chiadmi, Fouad ^a   Schlatter, Joël ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE; CENTRAL STIMULANT AGENT; STREET DRUG;

CRYSTAL STRUCTURE; DRUG DEPENDENCE; HUMAN; HYPERTENSION; PLACENTA; SEXUAL BEHAVIOR; SHORT SURVEY; TACHYCARDIA; CHEMICALLY INDUCED DISORDER; DRUG ABUSE; EUROPE; FRANCE; NEWBORN; NORTH AMERICA; REVIEW; WITHDRAWAL SYNDROME;

AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; EUROPE; FRANCE; HUMANS; HYPERTENSION; INFANT, NEWBORN; METHAMPHETAMINE; NEONATAL ABSTINENCE SYNDROME; NORTH AMERICA; STREET DRUGS; TACHYCARDIA;

EID: 57949087038     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.07.017     Document Type: Short Survey

References (35)

1. Ogata A. Constitution of ephedrine-desoxyephedrine. J Pharm Soc Japan 451 (1919) 751
2. Wolffenbuttel E. Use and abuse of pervitin. Rev bras med 20 (1963) 166
3. Hautefeuille M., and Véléa D. Les drogues de synthèse. Coll. « Que sais-je ? » (2002), Presses Universitaires de France, Paris
4. Logothetis J. Desoxyn therapy for nocturnal seizures ; a preliminary report. Neurology 5 (1955) 236-241
5. Schifano F., Corkery J.M., Cuffolo G., and Smokable. ("ice", "crystal meth") and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK. Ann Ist Super Sanita 43 (2007) 110-115
6. Anonyme. Addictions. Crystal meth research. Treatment Update 17 (2005) 4-5
7. Rapport mondial sur les drogues 2006.;1; Office des nations unies contre la drogue et le crime (ONUDC). http://www.unodc.org/pdf/WDR_2006/wdr06_french_vol1.www.pdf.
8. État du phénomène de la drogue en Europe. Rapport annuel 2006. Observatoire européen des drogues et des toxicomanies (OEDT). http://www.ofdt.fr/BDD/publications/docs/NR06rapp.pdf.
9. Anglin M.D., Burke C., Perrochet B., Stamper E., and Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 32 (2000) 137-141
10. Puthaviriyakorn V., Siriviriyasomboon N., Phorachata J., Pan-ox W., Sasaki T., and Tanaka K. Identification of impurities and statistical classification of methamphetamine tablets (Ya-Ba) seized in Thailand. Forensic Sci Int 126 (2002) 105-113
11. Lee J.S., Han E.Y., Lee S.Y., Kim E.M., Park Y.H., Lim M.A., et al. Analysis of the impurities in the methamphetamine synthesized by three different methods from ephedrine and pseudoephedrine. Forensic Sci Int 161 (2006) 209-215
12. Allen A.C. Methamphetamine from ephedrine: I. chloroephedrines and aziridines. Journal of Forensic Sciences 32 (1987) 953-962
13. Derlet R.W., and Heischober B. Methamphetamine. Stimulant of the 1990s?. West J Med 153 (1990) 625-628
14. Ellison J.M., and Dobies D.F. Methamphetamine abuse presenting as dysuria following urethral insertion of tablets. Ann Emerg Med 13 (1984) 198-200
15. Cook C.E., Jeffcoat A.R., Hill J.M., Pugh D.E., Patetta P.K., Sadler B.M., et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21 (1993) 717-723
16. Harris D.S., Boxenbaum H., Everhart E.T., Sequeira G., Mendelson J.E., and Jones R.T. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther 74 (2003) 475-486
17. Kim I., Oyler J.M., Moolchan E.T., Cone E.J., and Huestis M.A. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit 26 (2004) 664-672
18. Hautefeuille M. Les drogues de synthèse. Coll. « Que Sais-Je ? » (2002), Presses Universitaires de France, Paris
19. Shoptaw S., Reback C.J., Peck J.A., Yang X., Rotheram-Fuller E., Larkins S., et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 78 (2005) 125-134
20. Srikanth S., and Barua R. Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology 109 (2008) 188-192
21. Hong R., Matsuyama E., and Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 265 (1991) 1152-1154
22. Catanzarite V.A., and Stein D.A. 'Crystal' and pregnancy--methamphetamine-associated maternal deaths. West J Med 162 (1995) 454-457
23. Stewart J.L., and Meeker J.E. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol 21 (1997) 515-517
24. Smith L.M., LaGasse L.L., Derauf C., Grant P., Shah R., Arria A., et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118 (2006) 1149-1156
25. Chomchai C., Na Manorom N., Watanarungsan P., Yossuck P., and Chomchai S. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj hospital, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 35 (2004) 228-231
26. Office of national drug control policy. Drug facts : methamphetamine. Office of national drug control policy 2007; http://www.whitehousedrugpolicy.gov/drugfact/methamphetamine/index.html.
27. Zweben J.E., Cohen J.B., Christian D., Galloway G.P., Salinardi M., Parent D., et al. Methamphetamine treatment project. Psychiatric symptoms in methamphetamine users. Am J Addict 13 (2004) 181-190
28. Urbina A., and Jones K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 38 (2004) 890-894
29. Rhodus N.L., and Little J.W. Methamphetamine abuse and "meth mouth". Northwest Dent 84 (2005) 33-37
30. Shoptaw S. Methamphetamine use in urban gay and bisexual populations. Top HIV Med 14 (2006) 84-87
31. Nanín J.E., Parsons J.T., Bimbi D.S., Grov C., and Brown J.T. Community reactions to campaigns addressing crystal methamphetamine use among gay and bisexual men in New York City. J Drug Educ 36 (2006) 297-315
32. Cadet-Taïrou A., Gandilhon M., Toufik A., and Evrard I. Phénomènes émergents liés aux drogues en 2006. Huitième rapport national du dispositif TREND (2008), OFDT, Saint-Denis p. 188
33. Bolding G., Hart G., Sherr L., and Elford J. Use of crystal methamphetamine among gay men in London. Addiction 101 (2006) 1622-1630
34. Bunting P.J., Fulde G.W., and Forster S.L. Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency department. Med J Aust 187 (2007) 564-566
35. de la Santé et des Solidarités. La prise en charge et la prévention des addictions. Plan 2007-2011. http://www.sante.gouv.fr/htm/actu/plan_addictions_2007_2011/sommaire.htm.